EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Koninklijke Philips N.V (0LNG) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Koninklijke Philips N.V €18.38, price €21.14, upside -13.0%, quality 53 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · GB · ISIN NL0000009538

KP Some data Oct 2, 2026

Koninklijke Philips N.V

0LNG · LSE

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value €18.38 · Overvalued (−13.0%)
!Quality 53/100
!Weak Growth (revenue 3y −1.8 %/yr)
!Thin margins · 5.5% net margin (TTM)
✓Low debt
!4.0% dividend yield · Watch coverage
!Moderate moat 47/100
!Evidence only medium, so the estimate is less certain

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€32.45 €10.01 Fair Value €18.38 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.

How to read this chart

60‑month range €10.01 – €32.45 · fair‑value band €12.67 – €24.10 · the €21.14 price screens above the €18.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments.

Show more

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Stock analysis

Koninklijke Philips N.V (0LNG) currently trades at €21.14, while our model-based Fair Value estimate is €18.38, 13.0% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of €59.20 per share, and 6 of the 14 models we run sit above the €21.14 price.

Bear case: the Dividend Discount group reads lowest at €4.44, and 8 of the 14 models stay below the price. Evidence for this calculation is medium.

Scenario range: €12.67 (bear) to €24.10 (bull), the price of €21.14 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Koninklijke Philips N.V reported revenue of €17.2B in FY2021 versus €17.8B in FY2017, a compound −0.9%/yr. Reported net income was €3.3B in FY2021, compounding +19.0%/yr from FY2017.

Key figures

Market cap €19.7B · P/E ratio 0.1 · P/S ratio 0.01 · EPS (TTM) €3.50 · Dividend yield 4.0% · Net margin 19.3% · Return on equity 8.4% · Return on assets (EBIT) 5.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (medium confidence).

What moves the price

The share trades about 20% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at −13%, 0LNG screens richer than that median.

Fair Value models

Bear €12.67 Fair Value €18.38 Bull €24.10
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income €20.87 €24.29 €33.49 73
EPV €0.6100 €1.46 €2.20 69
Gordon GGM €4.06 €4.44 €5.03 67
All 14 models by family
Earnings-Based
Graham-Dodd €24.23 €29.61 €33.31 65
EPV €0.6100 €1.46 €2.20 69
Dividend Discount
Gordon GGM €4.06 €4.44 €5.03 67
DDM Multi-Stage €4.06 €5.10 €6.54 65
Multiples
P/E Multiple €58.79 €78.38 €97.98 63
P/S Multiple €45.43 €60.57 €75.71 58
P/B Multiple €45.43 €60.57 €75.71 55
EV/EBIT €3.09 €5.62 €8.14 63
EV/EBITDA €12.67 €18.38 €24.10 67
EV/Revenue €0.9300 €3.24 €5.56 49
Asset-Based
NCAV (Graham) €7.75 €10.39 €15.50 54
Economic Profit
Residual Income €20.87 €24.29 €33.49 73
ROIC Compounder €0.6100 €1.46 €2.20 66
Growth Earnings
Growth-Adj P/E €41.44 €59.20 €76.96 65

Open the full fair value analysis →

Notify me when 0LNG reaches fair value

Put 0LNG on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 53/100

Of which business quality 52 · Market factors (momentum, volatility) 38

Profitability 61
Margins and returns on capital today
Quality Growth 28
Are margins and returns improving?
Cashflow 56
Earnings quality: real cash, not paper profit
Fin. Strength 41
Balance sheet, leverage, solvency risk
Investment 80
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 31
Price trend over the last 3–12 months (market factor)
52W Momentum 15
Distance to the 52-week high (market factor)

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 6/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−12.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
8.5% (2017) → 3.2% (2021)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
not computed

0LNG screens overvalued: fair value 13% below the price. Compare with Abbott Laboratories, →

Compare Koninklijke Philips N.V with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $98.83 $74.79 −24%
Medtronic plc MDT $87.09 $65.61 −25%
Stryker Corporation SYK $278.77 $306.65 +10%
Boston Scientific Corporation BSX $43.65 $48.02 +10%
Edwards Lifesciences Corporation EW $85.19 $81.94 −4%
Siemens Healthineers AG SHL €37.86 €35.19 −7%
DexCom, Inc DXCM $86.68 $95.35 +10%
GE HealthCare Technologies Inc GEHC $66.63 $70.37 +6%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥153.86 ¥169.25 +10%
STERIS plc STE $208.93 $229.82 +10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Koninklijke Philips N.V · Fair Value
€18.38 −13%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Koninklijke Philips N.V Fair Value". https://www.fairvalue-calculator.com/stock/0LNG

Frequently asked questions

Is Koninklijke Philips N.V (0LNG) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of €18.38 versus a price of €21.14, about −13% upside (overvalued).
What is the fair value of 0LNG?
Our model-based fair value for Koninklijke Philips N.V is €18.38 (as of Oct 2, 2026), built from audited fundamentals. The current price: €21.14.
What is the quality score of 0LNG?
Koninklijke Philips N.V has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Koninklijke Philips N.V (0LNG)?
Our model-based price target is the fair value of €18.38 (as of Oct 2, 2026) from 14 valuation models. Cautious scenario €12.67, optimistic scenario €24.10. It is a calculation from audited fundamentals, not an analyst target.
What is the Koninklijke Philips N.V stock forecast for 2026?
Our models put fair value at €18.38, about −13% upside versus a price of €21.14 (overvalued). Cautious scenario €12.67, optimistic scenario €24.10. The calculation is refreshed regularly with new filings.
What is the revenue of Koninklijke Philips N.V (0LNG)?
Koninklijke Philips N.V reported trailing-twelve-month revenue of about €17.6B (latest available figure, as of Oct 2, 2026).
Does Koninklijke Philips N.V pay a dividend?
Koninklijke Philips N.V currently shows a dividend yield of about 4.02% relative to its recent price (as of Oct 2, 2026).
What is the intrinsic value of Koninklijke Philips N.V (0LNG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Koninklijke Philips N.V it is €18.38 per share (as of Oct 2, 2026), against a price of €21.14. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Koninklijke Philips N.V stock overvalued or undervalued in 2026?
As of Oct 2, 2026, 0LNG trades above its calculated fair value: price €21.14, fair value €18.38, a gap of about −13% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0LNG?
No. The price is what the market pays today (€21.14); the fair value is what the company's own numbers justify (€18.38). For Koninklijke Philips N.V the two are €2.76 per share apart. That gap is exactly why we show both numbers side by side.
How much is Koninklijke Philips N.V worth?
The market values Koninklijke Philips N.V at about €19.7B (market capitalisation, as of Oct 2, 2026). Per share that is €21.14; our models calculate a fair value of €18.38 per share.
What do the bullish and bearish scenarios say about 0LNG?
Our models span a range for Koninklijke Philips N.V: cautious scenario €12.67, base €18.38, optimistic €24.10 per share (as of Oct 2, 2026, price €21.14). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 0LNG from its 52-week high?
Koninklijke Philips N.V trades at €21.14, about 20% below its 52-week high of €26.55 and 1% above the low of €20.92 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of €18.38 is for.
Which stocks are comparable to Koninklijke Philips N.V?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Koninklijke Philips N.V stock attractive at the current price?
The data as of Oct 2, 2026: price €21.14, calculated fair value €18.38 (−13%), Quality Score 53/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0LNG calculated?
We run Koninklijke Philips N.V through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €18.38, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Koninklijke Philips N.V itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Koninklijke Philips N.V (0LNG)?
The closing price on Oct 2, 2026 was €21.14. Our model-based fair value is €18.38, about −13% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Koninklijke Philips N.V right now?
Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (€12.67 to €24.10) leaves room in how you read the outcome.

Key figures of Koninklijke Philips N.V

How large is the market capitalisation of Koninklijke Philips N.V (0LNG)?
The market capitalisation of Koninklijke Philips N.V is €19.7B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Koninklijke Philips N.V (0LNG)?
The price-to-earnings ratio of Koninklijke Philips N.V is 0.1 (as of Jul 26, 2026). Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What is the P/S ratio of Koninklijke Philips N.V (0LNG)?
The price-to-sales ratio of Koninklijke Philips N.V is 0.01 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Koninklijke Philips N.V (0LNG)?
Earnings per share at Koninklijke Philips N.V are €3.50 (price ÷ EPS = P/E 0.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Koninklijke Philips N.V (0LNG)?
The dividend yield of Koninklijke Philips N.V is 4.0% (payout 24.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Koninklijke Philips N.V (0LNG)?
The net margin of Koninklijke Philips N.V is 19.3% (fiscal year 2021). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Koninklijke Philips N.V (0LNG)?
The return on equity (ROE) of Koninklijke Philips N.V is 8.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Koninklijke Philips N.V (0LNG)?
On an EBIT basis the return on assets of Koninklijke Philips N.V is 5.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Koninklijke Philips N.V (0LNG)?
The operating margin of Koninklijke Philips N.V is 6.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Koninklijke Philips N.V (0LNG)?
Revenue at Koninklijke Philips N.V is growing −4.7% versus a year earlier (3y avg −1.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Koninklijke Philips N.V (0LNG)?
Earnings per share at Koninklijke Philips N.V are growing +97.2% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.